AnovoRx
Jon Peters is currently the President and CEO at AnovoRx, where Jon has been working since September 2012. Prior to that, Jon was the SVP of Operations and CFO at Accredo Healthcare. Jon also serves as the President of JBP Investments, focusing on private equity investing and advising. Jon started their career as a Senior Manager at Ernst & Young, where Jon worked until 2000.
AnovoRx
Dedicated. Exclusive. Unique. Anovo’s unique business is purpose-built exclusively for niche products designed to treat or impact rare diseases. As an all-in-one, exclusive partner, we are driven to deliver meaningful results for our partners and positive experiences for their patients. Coordinated by one management team, our integrated service model delivers customized program management, 3PL, specialty pharmacy, and patient care services. At Anovo, we’re solutions-oriented and focused on making a positive impact on behalf of our partners. Our team is uniquely suited to create a custom approach for each phase of the product lifecycle - from point of manufacture to patient experience. Find seamless management, meticulous quality checks, and appropriate solutions for every particular set of challenges through a single point of accountability and reassurance. We deliver to you exactly what we promise. To learn more about Anovo, visit http://www.anovorx.com today.